Cargando…
Update on liquid biopsy in clinical management of non-small cell lung cancer
Lung cancer, a leading cause of cancer-related mortality, has a low rate of early diagnosis and a poor prognosis for advanced stages. Recent advances in further mastery of the biology of tumors promote the diagnosis and therapy, especially for non-small cell lung cancer (NSCLC). However, tumor tissu...
Autores principales: | Wu, Zhen, Yang, Zhen, Dai, Yu, Zhu, Qiang, Chen, Liang-An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611714/ https://www.ncbi.nlm.nih.gov/pubmed/31303765 http://dx.doi.org/10.2147/OTT.S203070 |
Ejemplares similares
-
Future directions and management of liquid biopsy in non-small cell lung cancer
por: Cossu, Alessia Maria, et al.
Publicado: (2020) -
Liquid Biopsy in Non-Small Cell Lung Cancer
por: Molina-Vila, Miguel A., et al.
Publicado: (2016) -
Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer
por: Pesta, Martin, et al.
Publicado: (2022) -
Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
por: Shen, Haifeng, et al.
Publicado: (2022) -
The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer
por: Bożyk, Aleksandra, et al.
Publicado: (2022)